Prescription Required
T-PLANIN 400 MG Injection contains Teicoplanin (400 mg), a broad-spectrum glycopeptide antibiotic used to treat serious bacterial infections caused by Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus). T-PLANIN 400 MG Injection is administered under strict medical supervision, usually in a hospital setting, ensuring effective treatment for severe infections that do not respond to standard antibiotics.
Avoid alcohol during treatment to reduce the risk of liver damage.
Dose adjustments may be required in kidney impairment to prevent toxicity.
Use cautiously in liver disorders; regular liver function tests may be needed.
Use only if prescribed by a doctor after evaluating the risks.
Consult a doctor before use, as it may pass into breast milk.
May cause dizziness; avoid driving if you feel lightheaded.
The active ingredient, Teicoplanin, works by inhibiting bacterial cell wall synthesis, which is essential for bacterial growth and survival. This action leads to the weakening of the bacterial cell wall, causing the bacteria to burst and die. T-PLANIN is highly effective against multi-drug-resistant bacteria, including MRSA. This targeted approach helps eliminate infections that are difficult to treat with conventional antibiotics.
Severe bacterial infections occur when bacteria enter the bloodstream or deep tissues, causing life-threatening conditions. MRSA (Methicillin-resistant Staphylococcus aureus) is a type of bacteria that is resistant to many antibiotics, making infections difficult to treat.
T-PLANIN 400 MG Injection is a powerful glycopeptide antibiotic used to treat severe bacterial infections, including MRSA, sepsis, and pneumonia. It works by inhibiting bacterial cell wall synthesis, effectively eliminating resistant bacteria and preventing the spread of infection.
Content Updated on
Saturday, 8 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA